Page last updated: 2024-10-31

nabumetone and Body Weight

nabumetone has been researched along with Body Weight in 3 studies

Nabumetone: A butanone non-steroidal anti-inflammatory drug and cyclooxygenase-2 (COX2) inhibitor that is used in the management of pain associated with OSTEOARTHRITIS and RHEUMATOID ARTHRITIS.
nabumetone : A methyl ketone that is 2-butanone in which one of the methyl hydrogens at position 4 is replaced by a 6-methoxy-2-naphthyl group. A prodrug that is converted to the active metabolite, 6-methoxy-2-naphthylacetic acid, following oral administration. It is shown to have a slightly lower risk of gastrointestinal side effects than most other non-steroidal anti-inflammatory drugs.

Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.

Research Excerpts

ExcerptRelevanceReference
"A 6-month, double-blind, controlled, randomized, parallel study was performed to compare the efficacy and tolerance of nabumetone (1000 mg at bedtime) with naproxen (250 mg twice daily) in the treatment of osteoarthritis."9.06A 6-month, double-blind study comparing nabumetone to naproxen in the treatment of osteoarthritis. ( Goodman, LA; Pisko, EJ; Rice, D; Strader, K; White, R, 1987)
"A 6-month, double-blind, controlled, randomized, parallel study was performed to compare the efficacy and tolerance of nabumetone (1000 mg at bedtime) with naproxen (250 mg twice daily) in the treatment of osteoarthritis."5.06A 6-month, double-blind study comparing nabumetone to naproxen in the treatment of osteoarthritis. ( Goodman, LA; Pisko, EJ; Rice, D; Strader, K; White, R, 1987)
"Repeat oral dosing of nabumetone for 1 month maintains anti-inflammatory efficacy in a carrageenan model of paw oedema yet does not cause gastrointestinal damage."3.68Anti-inflammatory efficacy and gastrointestinal irritancy: comparative 1 month repeat oral dose studies in the rat with nabumetone, ibuprofen and diclofenac. ( Blower, PR; Gentry, C; Melarange, R; O'Connell, C, 1991)
"Nabumetone proved to be an effective anti-inflammatory agent that was devoid of gastrointestinal irritancy."1.29Nabumetone, an effective anti-inflammatory agent, lacks gastrointestinal irritancy in the rat when dosed orally for one month: comparison with tiaprofenic acid and etodolac. ( Blower, PR; Gentry, C; Melarange, R; Spangler, R; Toseland, CD, 1994)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Melarange, R2
Gentry, C2
Blower, PR2
Toseland, CD1
Spangler, R1
O'Connell, C1
Pisko, EJ1
Strader, K1
Rice, D1
White, R1
Goodman, LA1

Trials

1 trial available for nabumetone and Body Weight

ArticleYear
A 6-month, double-blind study comparing nabumetone to naproxen in the treatment of osteoarthritis.
    Pharmatherapeutica, 1987, Volume: 5, Issue:2

    Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Blood Pressure; Body Weight; Butanones; Clinic

1987

Other Studies

2 other studies available for nabumetone and Body Weight

ArticleYear
Nabumetone, an effective anti-inflammatory agent, lacks gastrointestinal irritancy in the rat when dosed orally for one month: comparison with tiaprofenic acid and etodolac.
    European journal of rheumatology and inflammation, 1994, Volume: 14, Issue:2

    Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Body Weight; Butanones; Carr

1994
Anti-inflammatory efficacy and gastrointestinal irritancy: comparative 1 month repeat oral dose studies in the rat with nabumetone, ibuprofen and diclofenac.
    Agents and actions. Supplements, 1991, Volume: 32

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Body Weight; Butanones; Carrageenan; Diclofenac; E

1991